OBX (Obsidian Therapeutics) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OBX Obsidian Therapeutics Inc OBX
8 GF Score
Price $27.50
View Full Analysis

What is Obsidian Therapeutics FCF Margin %?

Obsidian Therapeutics OBX -1.79% 8 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates OBX with a GF Score™ of 8/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Obsidian Therapeutics's Free Cash Flow for the six months ended in Dec. 2025 was $-90.47 Mil. Obsidian Therapeutics's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Obsidian Therapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Obsidian Therapeutics's current FCF Yield % is -16,900.00%.

The historical rank and industry rank for Obsidian Therapeutics's FCF Margin % or its related term are showing as below:


OBX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.63
* Ranked among companies with meaningful FCF Margin % only.

Obsidian Therapeutics FCF Margin % Related Terms

Obsidian Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Obsidian Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Obsidian Therapeutics FCF Margin % Chart

Obsidian Therapeutics Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Obsidian Therapeutics Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

OBX vs : FCF Margin % Comparison

For the Biotechnology subindustry, Obsidian Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Obsidian Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obsidian Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Obsidian Therapeutics's FCF Margin % falls into.


OBX
8GF Score
Obsidian Therapeutics Inc OBX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Obsidian Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Obsidian Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-90.466/0
= %

Obsidian Therapeutics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-90.466/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Obsidian Therapeutics (OBX) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Obsidian Therapeutics and its competitors.
Is Obsidian Therapeutics' FCF Margin % too high?
Obsidian Therapeutics' current FCF Margin % is 0.00%. Overall, Obsidian Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Obsidian Therapeutics' FCF Margin % compare to ?
Obsidian Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Obsidian Therapeutics and its competitors. Obsidian Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Obsidian Therapeutics stock overvalued right now?
Obsidian Therapeutics (OBX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Obsidian Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Obsidian Therapeutics (OBX), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Obsidian Therapeutics Business Description

Comparable Companies
Address 1030 Massachusetts Avenue, Suite 400, Cambridge, MA, USA, 02138
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
8GF Score

Get the complete analysis for OBX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.50
Price